Skip to main content

Table 2 Sociodemographics as predictors of first line ART failure in children with HIV/AIDS ¥ Treated in Four ART 3 Centers in Addis Ababa, Ethiopia followed from 2005-2011

From: Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first line anti-retroviral therapy

Covariate Treatment failure Treatment success Crude hazard risk (95 CI**) Adjusted hazard risk (95 CI**)
Age     
 -< 36 months 46(20.8) 175(79.2) 1.87(1.26-2.76) 1.85(1.24-2.76)
 -36-60 months 28(13.3) 183(86.7) 1.09(0.69-1.71) 1.09(0.69-1.72)
 ->60 months 93(12.3) 661(87.7) 1 1
Gender     
 -Female 96(15.8) 512(84.2) 1.34(0.96-1.86) 1.30(0.91-1.87)
 -Male 71(12.3) 506(87.7) 1 1
Primary Care Taker     
 -Parent (single/both) 119(14.5) 701(85.5) 1.13(0.78-1.61)  
 -Non-parent 48(13) 318(87) 1  
Care taker HIV sero-status     
 -Reactive 112(14.5) 661(85.5) 1.12(0.78-1.62)  
 -Unknown 47(13.1) 311(86.9) 1.13(0.50-2.53)  
 -Negative 8(14.5) 47(85.5) 1  
PMTCT Service     
 -Present 3(12.5) 21(87.5) 0.93(0.27-3.25)  
 -None 119(14.4) 705(85.6) 1.10(0.76-1.59)  
 -Unknown 45(13.3) 293(86.7) 1  
Infant ART prophylaxis     
 -Yes 5(18) 23(82) 1.97(0.67-5.81) 1.43(0.47-4.31)
 -None 144(14.7) 833(85.3) 1.57(0.93-2.63) 1.56(0.93-2.63)
 -Unknown 18(10) 163(90) 1 1
Disclosure£     
 -Disclosed 41(13.2) 270(86.8) 1.04(0.69-1.57)  
 Not disclosed 73(12.7) 501(87.3) 1  
  1. **Confidence interval £ Is telling children about their HIV status and was done for children older than 8 years ¥ Human Immunodeficiency virus/ Acquired Immunodeficiency syndrome 3 Antiretroviral therapy.